Bridging India’s IVF Access Gap: White Paper Urges Ayushman Bharat Inclusion and Insurance Reforms

NEW DELHI — A landmark policy document launched on World IVF Day during the 7th India IVF Summit in New Delhi is urging the Indian government to integrate fertility treatments into public health schemes and reform private insurance guidelines. The white paper, titled Beyond the Burden of Infertility in India: Towards Reproductive Equity through Mission Fertility 2.1, highlights a severe disparity in reproductive healthcare: while an estimated 35 million couples in India face infertility, only 4.2 million manage to access medical treatment each year. By advocating for the inclusion of in-vitro fertilisation (IVF) under Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), experts hope to transform fertility care from an out-of-reach luxury into a standard component of essential healthcare.

The Scale of Infertility and Financial Hurdles

India’s total fertility rate (TFR) has dropped below the replacement threshold of 2.1, reflecting shifting demographic trends alongside a growing prevalence of reproductive health challenges. According to World Health Organization (WHO) benchmarks cited by the Ministry of Health and Family Welfare, infertility affects approximately one in six adults globally, with recent epidemiological studies pointing to rising rates across India, particularly in southern states.

For most affected couples, accessing assisted reproductive technology (ART) remains financially prohibitive. A single cycle of IVF in India generally ranges from ₹1.5 lakh to ₹3 lakh. Given that many patients require two or three attempts to achieve a successful clinical pregnancy, cumulative costs escalate rapidly.

A 2026 Health Technology Assessment India (HTAIn) analysis released by the health ministry details the average out-of-pocket expenditure (OOPE) for a single IVF cycle:

These figures demonstrate that even within public institutions, direct patient spending remains substantial, pushing lower- and middle-income households into catastrophic health expenditure.

Five Strategic Recommendations for Policy Reform

The Mission Fertility 2.1 white paper outlines a strategic framework designed to remove structural, financial, and societal barriers to care:

• Policy Recognition: Explicitly recognise infertility as a core reproductive health condition within national health frameworks.

• Early Intervention & Awareness: Mobilise Accredited Social Health Activists (ASHAs), educational institutions, and workplaces to improve early diagnostics and dispel stigma, placing equal emphasis on male factor infertility.

• Private Insurance Overhaul: Reform insurance mandates by eliminating prolonged waiting periods and standardising coverage for ART procedures.

• Public Sector Reimbursements: Modernise reimbursement policies under the Central Government Health Scheme (CGHS), Employees’ State Insurance Corporation (ESIC), and public sector undertakings.

• State Financing & Workplace Integration: Expand public–private partnerships and encourage corporate employers to offer fertility coverage within standard employee wellness packages.

       [ National Recognition of Infertility ]
                        │
                        ▼
       [ Insurance & Reimbursement Reform ]
            (AB-PMJAY, CGHS, ESIC)
                        │
                        ▼
       [ Expanded Public Access & Care ]
 (Reduced OOPE, Early Diagnosis, Ethical Standards)

Current Coverage Gaps and Emerging Regional Prototypes

As of early 2026, the flagship Ayushman Bharat-PMJAY scheme provides up to ₹5 lakh per family annually for 1,961 procedures across 27 medical specialties. However, ART and advanced fertility services remain entirely excluded from its master benefit package.

To address this deficit, several regional health authorities have instituted localized models:

• Karnataka: The Arogya Karnataka scheme offers fully covered IVF/ICSI (Intracytoplasmic Sperm Injection) procedures for eligible Below Poverty Line (BPL) families, subsidising up to ₹1.30 lakh per cycle and ₹35,000 for frozen embryo transfers, capped at three lifetime cycles.

• Sikkim: Under the Vatsalya Yojana, the state government grants financial support up to ₹3 lakh for couples undergoing IVF treatments.

• Central Programmes: The Jiyo Parsi scheme provides direct financial subsidies for fertility care to preserve demographically vulnerable populations.

• State Proposals: Health departments in Rajasthan and Uttar Pradesh are currently evaluating clinical frameworks to integrate IVF benefit packages into state-sponsored insurance plans.

Expert Perspectives on Reproductive Equity

Leading medical professionals emphasize that integrating fertility services into national health systems is a matter of clinical necessity and social justice.

“IVF is ultimately about families waiting to hear a heartbeat. Delivering scientific excellence must go hand in hand with compassion and systemic support.”

— Dr. Sunita Tandulwadkar, President, Indian Society for Assisted Reproduction (ISAR)

Dr. Rishikesh Pai, founder of Bloom IVF Group and former president of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), noted the rapid expansion of India’s clinical infrastructure. “India has grown from housing roughly 10 IVF centers in its early years to around 5,000 facilities today,” Dr. Pai stated. “The primary focus of this next era must be access—achieved through increased awareness, physical availability, economic affordability, and strict ethical assurance.”

Kamal Narayan Omer, CEO of the Integrated Health and Wellbeing Council, added that the white paper serves as a strategic roadmap to ensure fertility care is treated as an essential component of basic health rights rather than an elective privilege.

Health Economics, Counterarguments, and Safeguards

While the public health imperative for reproductive equity is strong, economic analysts and public health administrators highlight competing challenges. Opponents of universal fertility coverage point to India’s existing burden of maternal mortality, infectious diseases, and non-communicable conditions, arguing that limited public funds must prioritize life-threatening illnesses. Furthermore, critics express concern over potential overutilization, commercial exploitation, or ethical oversights in cycle monitoring.

To mitigate these risks, regulatory frameworks such as the Assisted Reproductive Technology (Regulation) Act, 2021, and the Surrogacy (Regulation) Act, 2021, establish strict operational parameters. The white paper incorporates clear safeguard mechanisms to ensure fiscal responsibility:

• Establishing fixed caps on publicly funded cycles (e.g., maximum of two to three cycles per family).

• Restricting public reimbursements exclusively to accredited, registered ART clinics.

• Prioritizing economically vulnerable demographics through socio-economic screening.

Practical Outlook for Patients and Healthcare Providers

If adopted, the recommendations of the Mission Fertility 2.1 white paper could significantly alter the delivery of reproductive healthcare across India:

For Patients

• Reduced Out-of-Pocket Burden: Inclusion in schemes like Ayushman Bharat would lessen the need for personal loans or distress financing to afford treatment.

• Shorter Insurance Waiting Periods: Regulatory reforms in private insurance would streamline claim approvals for young couples facing early diagnoses.

• Employer Support: Increased adoption of fertility benefits within private corporate insurance packages.

For Clinical Providers

• Standardized Quality Metrics: Integration into public financing requires clinics to adhere to audited outcome reporting and ethical practices.

• Increased Patient Volume: Early diagnosis through primary healthcare workers (such as ASHAs) will help direct patients to timely, evidence-based care rather than delayed, empirical interventions.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

1. ET HealthWorld. “White paper seeks insurance reforms, Ayushman Bharat fertility cover to improve IVF access.” Economic Times HealthWorld, 28 July 2026. https://health.economictimes.indiatimes.com/news/industry/white-paper-seeks-insurance-reforms-ayushman-bharat-fertility-cover-to-improve-ivf-access/132702831